Endava price target lowered to $112 from $120 at Susquehanna

Susquehanna analyst James Friedman lowered the firm’s price target on Endava to $112 from $120 and keeps a Positive rating on the shares. The analyst said In light of recent peer group commentary, macro developments, and read-throughs, we are lowering near-term estimates modestly.